Page last updated: 2024-11-07

idoxuridine and Multiple Sclerosis

idoxuridine has been researched along with Multiple Sclerosis in 2 studies

Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frey, H1
Molnár, G1
Barbosa, LH1
Hamilton, R1

Other Studies

2 other studies available for idoxuridine and Multiple Sclerosis

ArticleYear
Spontaneous and PHA stimulated lymphocyte transformation in multiple sclerosis patients during and after acute exacerbations with special reference to steroid therapy.
    Acta neurologica Scandinavica, 1977, Volume: 55, Issue:6

    Topics: Female; Humans; Idoxuridine; Lectins; Lymphocyte Activation; Male; Multiple Sclerosis; Prednisone; T

1977
Virological studies with multiple-sclerosis brain tissues.
    Lancet (London, England), 1973, Jun-23, Volume: 1, Issue:7817

    Topics: Adult; Antibodies, Viral; Brain; Cells, Cultured; Culture Techniques; Female; Fluorescent Antibody T

1973